OPINION
Published on 10 Dec 2024
Revisiting immune checkpoint inhibitors: new strategies to enhance efficacy and reduce toxicity
doi 10.3389/fimmu.2024.1490129
- 365 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immune-Checkpoint Inhibitors and Immunometabolic Reprogramming in Cancer Immunotherapy
Immune-Checkpoint Inhibitors and Immunometabolic Reprogramming in Cancer Immunotherapy
2,414
Total downloads
6,846
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
SYSTEMATIC REVIEW
Published on 18 Oct 2024
Prognostic value of inflammatory markers NLR, PLR, LMR, dNLR, ANC in melanoma patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review
doi 10.3389/fimmu.2024.1482746
- 572 views
REVIEW
Published on 04 Oct 2024
Improving efficacy of TNBC immunotherapy: based on analysis and subtyping of immune microenvironment
doi 10.3389/fimmu.2024.1441667
- 920 views
SYSTEMATIC REVIEW
Published on 01 Oct 2024
Efficacy and safety of immune checkpoint inhibitors as neoadjuvant therapy in perioperative patients with non-small cell lung cancer: a network meta-analysis and systematic review based on randomized controlled trials
doi 10.3389/fimmu.2024.1432813
- 1,209 views
OPINION
Published on 12 Jul 2024
Microbiota-metabolism-epigenetics-immunity axis in cancer
doi 10.3389/fimmu.2024.1449912
- 1,216 views
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted:
Impact
- 6,846Topic views
- 3,956Article views
- 2,414Article downloads